OpenEvidence weighs $200 million raise at $20 billion valuation

The reported round would mark a sharp step-up from the AI healthcare platform’s $12 billion valuation and test investor appetite for richly priced private AI companies.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.